Drug Type ASO |
Synonyms Obeversen Sodium, ION-769357 |
Target |
Action inhibitors |
Mechanism DGAT2 inhibitors(Diacylglycerol O-acyltransferase 2 inhibitors), RNA interference |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Nonalcoholic Steatohepatitis | Preclinical | United States | - |